Search Results 531-540 of 11874 for Open-angle glaucoma

  1. Phase III Open Label First Line Therapy Study Of MEDI 4736 (Durvalumab) With Or Without Tremelimumab Versus SOC In Non Small-Cell Lung Cancer (NSCLC). - Mayo Clinic

    Phase III Open Label First Line Therapy Study Of MEDI 4736 (Durvalumab) With Or Without Tremelimumab Versus SOC In Non Small-Cell Lung Cancer (NSCLC). Print ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Amar Miglani, M.D.. Otolaryngologist. Phoenix, AZ. Areas of focus: Lacrimal surgery, Endoscopic orbital surgery, Open skull base surgery, Endoscopic pituitary ...

  3. Brighter view thanks to eyelid lift - Mayo Clinic News Network

    And there was no slowing down for her in retirement either. The day after she retired from North High School, she hit the open road for a monthlong motorcycling ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Amar Miglani, M.D.. Otolaryngologist. Phoenix, AZ. Areas of focus: Lacrimal surgery, Endoscopic orbital surgery, Open skull base surgery, Endoscopic pituitary ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Amar Miglani, M.D.. Otolaryngologist. Phoenix, AZ. Areas of focus: Lacrimal surgery, Endoscopic orbital surgery, Open skull base surgery, Endoscopic pituitary ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Otolaryngologist. Phoenix, AZ. Areas of focus: Lacrimal surgery, Endoscopic orbital surgery, Open skull base surgery, Endoscopic pituitary surgery, Endoscopic ...

  7. Mayo Clinic Department of Ophthalmology - Doctors

    Tyler M. Kaplan, M.D.. Ophthalmologist. Rochester, MN. Areas of focus: Cataract surgery, Goniotomy, Glaucoma drainage device surgery, Laser peripheral ...

  8. Neurology - Clinical trials - Mayo Clinic

    Clinical trials. Below are current clinical trials. 103 studies in Neurology (open studies only) ...

  9. An Open-label Multi-Cohort Phase 1b/2 Study To Evaluate The Safety, Efficacy, And Optimal Dose Of Telisotuzumab Adizutecan In Combination With A PD-1 Immune Checkpoint Inhibitor In Advanced Or Metastatic Non-Squamous NSCLC With No Prior Treatment For Advanced Disease And No Actionable Genomic Alterations (AndroMETa-Lung-536) - Mayo Clinic

    Non small cell lung carcinoma (NSCLC) is the most frequently occurring histologic subtype of lung cancer and is the leading cause of cancer-related deaths ...

  10. Fuchs dystrophy - Symptoms and causes - Mayo Clinic

    This causes your cornea to swell and thicken, leading to glare, blurred or cloudy vision, and eye discomfort. Fuchs (fewks) dystrophy usually affects both eyes.